Outlook Therapeutics takes a major step forward in its plan to gain approval for wet AMD drug Lytenava; the first commercial FLIGHT procedures using the ViaLuxe Laser System are performed in Europe; and Oculus introduces a new AI-assisted tool designed to help clinicians evaluate MGD using meibography images.

Learn more about your ad choices. Visit megaphone.fm/adchoices

The FDA approves wireless pressure-modulating goggles for at-home glaucoma treatment; Bausch + Lomb launches a new PreserVision AREDS eye vitamin formation; and an Executive Strategic Advisor discusses the regulation environment for communication in eye care. 

Learn more about your ad choices. Visit megaphone.fm/adchoices

Leading ophthalmologists join us to discusses the hottest topics in the posterior segment treatment landscape. 

Learn more about your ad choices. Visit megaphone.fm/adchoices

Bayer expands ophthalmology pipeline with acquisiton of Perfuse Therapeutics; Viridian announces new phase 3 data for its investigational subcutaneous injection for chronic thyroid eye disease; and Steven Dell, MD discusses the impact of declining reimbursement could on ophthalmic practices.

Learn more about your ad choices. Visit megaphone.fm/adchoices

Ophthalmic executives discuss strategies to scale and grow in today’s economic and regulatory environments. 

Learn more about your ad choices. Visit megaphone.fm/adchoices

Glaukos commercially launches its topical drug therapy for keratoconus; BVI’s next-generation phaco-vitrectomy surgical system receives CE Mark; and the ASCRS Executive Director recaps the 2nd annual Sightline meeting. 

Learn more about your ad choices. Visit megaphone.fm/adchoices

Eyewire reports on new products and breaking news live from the American Society of Cataract and Refractive Surgery meeting in Washington DC. 

Learn more about your ad choices. Visit megaphone.fm/adchoices

A major recall is announced for several store-brand OTC eye drops; the FDA extends dosing intervals for Eylea HD in patients with Wet AMD and DME; and Bausch + Lomb launches its second full range of vision IOL in Europe.

Learn more about your ad choices. Visit megaphone.fm/adchoices

Pharma giant Biogen announces its intention to acquire Apellis in a multi-billion dollar deal; a recently approved first-of-its-kind presbyopia drop is commercially launched; and Kodiak Sciences releases phase 3 data for its diabetic retinopathy drug candidate.

Learn more about your ad choices. Visit megaphone.fm/adchoices

The Executive Director of The American Society of Cataract & Refractive Surgery (ASCRS) previews the upcoming annual meeting and discusses the most pressing issues facing ophthalmology. 

Learn more about your ad choices. Visit megaphone.fm/adchoices